Clinical trials
Hypertension trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Unknown status | 7 |
| Recruiting | 5 |
| Terminated | 5 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 9 |
| Boehringer Ingelheim | 8 |
| Coordinación de Investigación en Salud, Mexico | 5 |
| Sanofi | 5 |
| Instituto Mexicano del Seguro Social | 3 |
| Mexican National Institute of Public Health | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2 |
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 75 |
| Cardiovascular Diseases | 12 |
| Obesity | 12 |
| Diabetes Mellitus, Type 2 | 10 |
| Diabetes Mellitus | 8 |
| Essential Hypertension | 6 |
| Metabolic Syndrome | 5 |
| Renal Insufficiency, Chronic | 5 |
| Heart Failure | 4 |
| Hyperglycemia | 4 |
Trials
Showing 51 to 75 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.